By Rishika Sadam and Kashish Tandon Dec 12 (Reuters) - Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg ...

Americans without health insurance could be paying more than 10 times as much for the weight-loss drugs.

In an exclusive interaction with NDTV, Managing Director of Novo Nordisk India, Vikrant Shrotriya, said the launch of ...

A medical expert warned of the side effects of the newly launched weight loss drug Ozempic.

Vikrant Shrotriya, Novo Nordisk India MD responds to questions on future pricing, generics competition post patent expiry in March, Indian-specific pricing, demand in India & quality. “India is not a ...

In an interview, Novo Nordisk India’s managing director Vikrant Shrotriya discusses the launch of Ozempic, the company’s ...

Novo Nordisk has launched Ozempic in India at ₹2,200 per week, expanding diabetes treatment options even as patent disputes ...

Ozempic is now available in India as 0.25 mg, 0.5 mg and 1 mg in 'FlexTouch Pen' - an easy-to-use, once-weekly pen device, at ...

“Sensitive to Indian socioeconomic class”, Novo Nordisk MD on introducing Ozempic at ₹2,200 per week ...

By Rishika Sadam HYDERABAD, India, Dec 3 (Reuters) - Danish drugmaker Novo Nordisk will launch its blockbuster diabetes drug ...

India's GLP-1 race intensifies with the launch of Ozempic ...

Danish pharmaceutical giant Novo Nordisk has introduced its type 2 diabetes treatment, Ozempic, in India. Positioned as a ...